×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by SQUINTO STEPHEN P

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SWTXSpringWorks Therapeutics, Inc.SQUINTO STEPHEN PDirectorApr 27, 2021Sale$75.0520115,085144,959Apr 28, 2021, 08:18 PM
SWTXSpringWorks Therapeutics, Inc.SQUINTO STEPHEN PDirectorApr 28, 2021Sale$76.2019,2311,465,437125,728Apr 28, 2021, 08:18 PM
SWTXSpringWorks Therapeutics, Inc.SQUINTO STEPHEN PDirectorApr 15, 2021Sale$75.011,05779,291145,160Apr 19, 2021, 06:07 AM
SWTXSpringWorks Therapeutics, Inc.SQUINTO STEPHEN PDirectorApr 14, 2021Sale$75.0851138,365146,217Apr 19, 2021, 06:07 AM
SWTXSpringWorks Therapeutics, Inc.SQUINTO STEPHEN PDirectorSep 17, 2019Buy$18.00275,0004,950,0007,406,307Sep 19, 2019, 07:12 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerOct 27, 2014Sale$127.6311,4601,462,671112,418Oct 28, 2014, 05:41 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerOct 03, 2014Sale$107.5320,0502,156,040116,893Oct 07, 2014, 08:13 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerSep 24, 2014Sale$159.507612,122106,868Sep 26, 2014, 05:53 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerAug 04, 2014Sale$157.421,662261,632106,944Aug 05, 2014, 04:55 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerFeb 06, 2014Option Exercise$124.477,600945,97298,618Feb 10, 2014, 06:47 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerFeb 07, 2014Sale$155.571,620252,030102,963Feb 10, 2014, 06:47 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerFeb 10, 2014Sale$167.311,635273,552101,308Feb 10, 2014, 06:47 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerFeb 03, 2014Sale$157.14852133,883102,216Feb 05, 2014, 07:58 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerFeb 04, 2014Option Exercise$111.9164,8767,260,250124,455Feb 05, 2014, 07:58 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerJan 29, 2014Sale$133.311,118149,039103,086Jan 31, 2014, 05:30 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerNov 04, 2013Sale$77.7628,2502,196,626118,311Nov 05, 2013, 06:50 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerOct 28, 2013Sale$123.891,000123,890104,186Oct 30, 2013, 05:59 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerOct 28, 2013Sale$102.8980,0748,239,079145,223Oct 30, 2013, 05:59 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerSep 24, 2013Sale$112.5430434,212105,186Sep 26, 2013, 04:59 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerSep 13, 2013Sale$114.371,000114,370105,490Sep 17, 2013, 06:09 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerAug 05, 2013Sale$116.8785299,573106,490Aug 07, 2013, 05:27 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerAug 02, 2013Option Exercise$73.4928,2502,075,981121,467Aug 02, 2013, 05:02 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerJul 30, 2013Sale$110.861,120124,163107,342Aug 01, 2013, 05:04 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Chief Global Ops. OfficerJul 12, 2013Sale$70.4636,0002,536,570126,462Jul 16, 2013, 04:47 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Global Ops. OfficerJul 01, 2013Sale$67.0588,2505,917,385152,587Jul 03, 2013, 04:49 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Global Ops. OfficerApr 29, 2013Sale$66.3572,9984,843,078144,961May 01, 2013, 06:29 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Head of R&DMar 08, 2013Option Exercise$55.4440,0002,217,512128,462Mar 12, 2013, 04:39 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Head of R&DFeb 04, 2013Sale$95.682,572246,08181,977Feb 06, 2013, 06:07 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Head of R&DJan 29, 2013Sale$94.3276772,34384,497Jan 30, 2013, 05:23 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Head of R&DJan 28, 2013Sale$94.5071567,56885,264Jan 30, 2013, 05:23 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJul 27, 2012Sale$64.27200,66812,896,429187,662Jul 31, 2012, 04:44 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJul 31, 2012Sale$105.011,015106,58585,979Jul 31, 2012, 04:44 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJul 09, 2012Sale$59.21100,0005,920,772137,662Jul 11, 2012, 04:26 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJun 06, 2012Sale$53.82100,0005,382,500137,662Jun 08, 2012, 03:34 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentFeb 17, 2012Sale$49.23110,5205,440,986142,922Feb 22, 2012, 05:23 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJan 27, 2012Sale$74.4166349,33477,626Jan 30, 2012, 05:03 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJan 30, 2012Sale$74.513,004223,82874,662Jan 30, 2012, 05:03 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJan 10, 2012Sale$75.0056242,15078,289Jan 11, 2012, 05:26 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentOct 24, 2011Sale$40.61105,4804,283,055131,591Oct 25, 2011, 04:00 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJul 26, 2011Sale$33.8256,0001,893,640106,270Jul 27, 2011, 04:52 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJul 27, 2011Sale$57.2766938,31477,601Jul 27, 2011, 04:52 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentJul 11, 2011Sale$50.0050225,10078,270Jul 12, 2011, 04:09 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research & DevelopmentMar 02, 2011Option Exercise$59.8510,000598,45044,637Mar 04, 2011, 03:50 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP, Research and DevelopmentFeb 18, 2011Option Exercise$57.5020,0001,150,00049,637Feb 23, 2011, 04:53 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP & Head of R&DJan 27, 2011Sale$84.701,330112,65132,917Jan 28, 2011, 04:29 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP & Head of R&DJan 18, 2011Option Exercise$49.9768,3463,415,28068,247Jan 18, 2011, 05:03 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP & Head of R&DJan 10, 2011Sale$81.2728022,75634,593Jan 12, 2011, 01:02 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP & Head of R&DNov 03, 2010Option Exercise$40.2520,000805,00044,873Nov 05, 2010, 04:30 PM
ALXNALEXION PHARMACEUTICALS INCSQUINTO STEPHEN PEVP & Head of R&DSep 13, 2010Sale$35.9824,832893,35742,289Sep 13, 2010, 04:36 PM